Wun-Hao Cheng

Dr. Wun-Hao Cheng

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

29 August 2025 in Sleep Medicine
Verified
Journal Article
Closed access
JSJia-Wei Sun
Jia-Wei Sun
HHHsiang-Chih Hsu
Hsiang-Chih Hsu
JWJie-Syuan Wu
Jie-Syuan Wu
THTsai-Wei Huang
Tsai-Wei Huang
YTYuan-Si Tsai
Yuan-Si Tsai
LLLee-Yuan Lin
Lee-Yuan Lin

18 February 2026 in Inflammation
Verified
Journal Article
Open access
PDF file
WCWun-Hao Cheng
Wun-Hao Cheng
YWYu-Chih Wu
Yu-Chih Wu
HLHsuan-Tzu Li
Hsuan-Tzu Li
CWChih-Ming Weng
Chih-Ming Weng
LLLee-Yuan Lin
Lee-Yuan Lin
FYFara Silvia Yuliani
Fara Silvia Yuliani
Severe asthma is characterized by subepithelial fibrosis and mitochondrial dysfunction in bronchial fibroblasts. Fibronectin type III domain-containing 5 (FNDC5)/irisin modulates metabolism and protects mitochondria during inflammation, but its role in fibroblast differentiation remains unclear. In this study, we assessed FNDC5 expression in bronchial tissues from house dust mite (HDM)–induced asthmatic mice and controls by immunohistochemistry, analyzed fibrotic proteins by Western blotting, performed RNA sequencing to identify antioxidant pathway–associated genes, evaluated mitochondrial function using JC-1 staining, and measured airway hyperresponsiveness (AHR) with the FlexiVent system. FNDC5 levels were reduced in asthma-derived lung fibroblasts and in HDM-induced asthmatic mice compared to controls. Treatment with irisin decreased α-SMA expression, improved mitochondrial function, and suppressed TGF-β–induced fibrotic protein expression and Smad3 phosphorylation in human lung fibroblasts. RNA sequencing confirmed that irisin enhanced antioxidant-related gene expression and activated the AMPK pathway, which in turn reduced TGF-β–induced Smad3 phosphorylation and fibronectin expression. Moreover, irisin induced Nrf2 phosphorylation, and Nrf2 knockdown diminished its protective effects on fibrosis markers. In vivo, irisin treatment alleviated HDM-induced airway fibrosis, inflammation, and lung function impairments. Together, these findings demonstrate that FNDC5/irisin protects against airway fibrosis in patients with asthma by activating AMPK and Nrf2 signaling pathways, thereby preserving mitochondrial function and reducing fibroblast differentiation, highlighting FNDC5/irisin as a potential therapeutic target for airway remodeling in asthma.

14 October 2022 in JMIR Preprints
Verified
Preprint
Open access
CTCheng-Yu Tsai
Cheng-Yu Tsai
Wen-Te LiuWen-Te Liu
Wen-Te Liu
WHWen-Hua Hsu
Wen-Hua Hsu
Arnab MajumdarArnab Majumdar
Arnab Majumdar
MSMarc Stettler
Marc Stettler
SHShu-Chuan Ho
Shu-Chuan Ho
BACKGROUND Obstructive sleep apnea (OSA) is sleep-disordered breathing and is typically diagnosed by polysomnography (PSG). However, PSG is time-consuming and has some clinical limitations. OBJECTIVE This study thus aimed to establish machine learning models to screen for the risk of having moderate-to-severe and severe OSA based on easily acquired features (e.g., symptoms or risk factors of OSA). METHODS This retrospective study collected data on 3629 patients from Taiwan, who had undergone PSG for symptoms of OSA. Their baseline characteristics, anthropometric measures, and PSG data were obtained. The number of snoring events of PSG was further derived, and correlations among the collected variables were investigated. Next, this study utilized six common supervised machine learning techniques to establish OSA risk screening models, including random forest (RF), XGBoost, k-nearest neighbors, support vector machine, logistic regression, and naïve Bayes. First, data were independently separated into a training and validation dataset (80%) and a test dataset (20%). The approach which had the highest accuracy in the training and validation phase was employed to perform the classification for the test dataset. Moreover, the feature importance of employed models was determined by calculating the Shapley value of every factor, which represented the impact on OSA risk screening. RESULTS RF models manifested the highest accuracy and area under the receiver operating characteristic curve (AUC) in the training and validation phase in screening for both OSA severities (over 70% of accuracy and over 80% of AUC). Hence, we employed the RF to perform the classification of the independent test dataset, and results showed 79.32% accuracy for moderate-to-severe OSA and 74.37% accuracy for severe OSA. Next, snoring events and the visceral fat level were the most and second-most essential features of screening for OSA risk. CONCLUSIONS Snoring events and the visceral fat level were essential features of screening for OSA risk. Based on these easily assessed variables, this study established models that can be considered to apply for screening OSA risk in populations with similar craniofacial features.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
WCWun-Hao Cheng
Wun-Hao Cheng
Severe asthma is characterized by persistent airway inflammation and subepithelial fibrosis. Mitochondrial dysfunction plays a crucial role in bronchial fibroblast differentiation and resistance to apoptosis, exacerbating subepithelial fibrosis. Fibronectin type III domain containing 5 (FNDC5)/irisin plays a crucial role in modulating metabolism and protecting mitochondria during inflammation through AMP-activated protein kinase (AMPK) phosphorylation, potentially alleviating the progression of chronic diseases. AMPK activation induces osteoblast differentiation via the Smad1/5/9 pathway. However, whether TGF-β reduces FNDC5 via the AMPK/smad1/5/9 pathway in normal human lung fibroblasts (NHLFs) remains unknown. This research project aims to explore the role of FNDC5/irisin in alleviating airway subepithelial fibrosis by regulating mitochondrial function in severe asthma. Preliminary data indicated reduced FNDC5 expression in severe asthma bronchial tissue and fibroblasts. Irisin downregulated α-SMA expression dose-dependently, alleviating mitochondrial dysfunction in asthma fibroblasts. FNDC5 expression was decreased in OVA-induced airway fibrosis mice. RNA-sequence analysis showed reduced Fndc5 expression in OVA-induced asthmatic mice. TGF-β decreased FNDC5 expression and AMPK phosphorylation in a time-dependent manner in NHLFs. Moreover, irisin decreased TGF-β-induced α-SMA and fibronectin expression and Smad3 phosphorylation in NHLFs. Additionally, irisin affected mitochondrial-associated cellular components, biological processes, and molecular functions compared to TGF-β-treated NHLFs. Therefore, this research project's central hypothesis is that FNDC5/irisin down-regulates TGF-β-induced mitochondrial dysfunction in subepithelial fibrosis in severe asthma.

22 May 2026 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
LLLee-Yuan Lin
Lee-Yuan Lin
WCWun-Hao Cheng
Wun-Hao Cheng
YWYu-Chih Wu
Yu-Chih Wu
HWHeng-Ching Wen
Heng-Ching Wen
HHHsao-Hsun Hsu
Hsao-Hsun Hsu
BCBing-Chang Chen Chen
Bing-Chang Chen Chen
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease with limited treatment options. Although the results of a gene expression analysis revealed that lung tissues in individuals with IPF contain high levels of doublecortin-like kinase 1 (DCLK1), the role of DCLK1 in fibroblast activation remains unclear. The present study examined the function of DCLK1 in IPF and bleomycin-induced pulmonary fibrosis, exploring its potential as a therapeutic target warranting further investigation. Methods: We investigated the role of DCLK1 in fibroblast activation and pulmonary fibrosis in lung tissues from patients with IPF, a bleomycin-induced pulmonary fibrosis mouse model, and cultured normal human lung fibroblasts. DCLK1 knockout mice and mice treated with the selective DCLK1 inhibitor DCLK1-IN-1 were used to evaluate the effects of genetic DCLK1 deficiency and pharmacological DCLK1 inhibition on fibrotic progression and lung function. Results: DCLK1 was markedly upregulated in the IPF lung tissues and in bleomycin-induced fibrotic lung tissues. Global deletion of Dclk1 considerably attenuated fibrotic remodeling and preserved lung function in mice. In addition, transforming growth factor β (TGF-β) induced DCLK1 expression in normal human lung fibroblasts through Smad3 and NF-κB signaling, while Akt/DCLK1/Smad3 signaling was associated with fibroblast activation and profibrotic marker expression. Moreover, DCLK1 was associated with Smad3, and these findings were consistent with DCLK1–Smad3-associated signaling linked to connective tissue growth factor expression. Finally, oral administration of DCLK1-IN-1 slowed fibrotic progression and preserved lung function in bleomycin-treated mice. Conclusions: DCLK1 is associated with fibroblast activation and pulmonary fibrosis, with findings consistent with DCLK1–Smad3-associated signaling linked to profibrotic marker expression. Genetic deletion or pharmacological inhibition of DCLK1 attenuated fibrotic progression and preserved lung function, suggesting that DCLK1 warrants further investigation as a potential therapeutic target in pulmonary fibrosis.